Sirolimus News and Research

RSS
Svelte completes enrollment in DIRECT drug-eluting stent study

Svelte completes enrollment in DIRECT drug-eluting stent study

Cardionovum to introduce two DEB dilatation catheter product families

Cardionovum to introduce two DEB dilatation catheter product families

FDA approves Novartis’ Afinitor for treatment of renal angiomyolipomas and TSC

FDA approves Novartis’ Afinitor for treatment of renal angiomyolipomas and TSC

Disrupting mTORC1 protein complex extends lifespan

Disrupting mTORC1 protein complex extends lifespan

Center for LAM Research and Clinical Care at BWH to conduct phase I combination drug trial

Center for LAM Research and Clinical Care at BWH to conduct phase I combination drug trial

Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer

Updated data from Novartis Afinitor plus everolimus Phase III study on advanced breast cancer

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Elixir Medical announces initiation of DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System study

Elixir Medical announces initiation of DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System study

Svelte initiates Rapamycin-eluting stent with bio-Eroding Carrier Technology implantation study

Svelte initiates Rapamycin-eluting stent with bio-Eroding Carrier Technology implantation study

Micell announces preliminary data from MiStent Sirolimus DES clinical study

Micell announces preliminary data from MiStent Sirolimus DES clinical study

DSM and Svelte Medical Systems enter into license and supply agreement

DSM and Svelte Medical Systems enter into license and supply agreement

Gilead, CRF commence ranolazine Phase 3 clinical trial for chronic stable angina in post-PCI setting

Gilead, CRF commence ranolazine Phase 3 clinical trial for chronic stable angina in post-PCI setting

Afinitor Phase III study on angiomyolipomas associated with TSC meets primary endpoint

Afinitor Phase III study on angiomyolipomas associated with TSC meets primary endpoint

Combination of Afinitor, exemestane reduces risk of breast cancer progression in women

Combination of Afinitor, exemestane reduces risk of breast cancer progression in women

TCT to showcase major scientific research breakthroughs in cardiovascular medicine

TCT to showcase major scientific research breakthroughs in cardiovascular medicine

CRF announces late breaking trials & first report investigations to be presented at TCT 2011

CRF announces late breaking trials & first report investigations to be presented at TCT 2011

EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis

EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis

Everolimus-eluting stent reduces incidence of stent thrombosis

Everolimus-eluting stent reduces incidence of stent thrombosis

Everolimus-eluting stent and SES are equally effective for PCI patients

Everolimus-eluting stent and SES are equally effective for PCI patients

OrbusNeich's Genous Stent safe, effective for patients at high risk of restenosis

OrbusNeich's Genous Stent safe, effective for patients at high risk of restenosis